For many years, researchers and clinicians assumed that nutrition was a one-size-fits-all affair. Everybody needs the same nutrients from their food, they thought, and a vitamin pill or two could help dispense with any deficiencies.
But now scientists are learning that our genes and environment, along with the microbes that dwell in us and other factors, alter our individual abilities to make and process nutrients. These differences mean that two given people can respond to identical diets in different ways, contributing to varied health outcomes and patterns of disease.
Until recently, scientists didn't fully appreciate that individual metabolic differences can have a big impact on how diet affects the risk for chronic diseases, says Steven Zeisel, director of the Nutrition Research Institute at the University of North Carolina, Chapel Hill. The new knowledge is resolving long-standing mysteries about human health and paving the way toward a world of "precision nutrition," Zeisel writes in a recent article in the Annual Review of Food Science and Technology.
Although the findings are unlikely to lead all the way to hyper-individualized dietary recommendations, they could help to tailor nutrition to subsets of people depending on their genetics or other factors: Zeisel's company, SNP Therapeutics, is working on a test for the genetic patterns of 20-odd variants that can identify individuals at risk of fatty liver disease, for example. Knowable Magazine spoke with Zeisel about our developing understanding of precision nutrition.
This interview has been edited for length and clarity.
Why has nutrition lagged behind other research areas in medicine?
Nutrition studies have always had a problem with variability in experimental results. For instance, when infants were given the fatty acid DHA [docosahexaenoic acid], some had an improvement in their cognitive performance and others didn't. Because some showed improvements, it was added to infant formula. But we didn't understand why they were responding differently, so scientists continued to debate why we did this if only 15 percent of children improved and 85 percent showed no response.
The confusion came from an expectation that everybody was essentially the same. People didn't realize that there were predictable sources of variation that could separate those who responded to something from those who did not. For DHA, it turned out that if the mother had a difference in her genes that made her slow to produce DHA, then her baby needed extra DHA and responded when given it. That gene difference occurs in about 15 percent of women and, it turns out, it's their babies that get better when given DHA.
How are researchers starting to make sense of this variability?
Studying differences in human genetics is one way. We conducted a series of studies that found a good deal of variation in the amounts of choline [an essential nutrient] that people required: Men and postmenopausal women got sick when deprived of it, but only half of young women became sick.
We found that some women can make choline because the hormone estrogen turns on the gene to make choline. Other women have a difference in this gene that makes it unresponsive to estrogen. Men and postmenopausal women need to get the nutrient another way by eating it because they have minimal amounts of estrogen.
If I had initially done the choline study and chosen only young women participants, I would have found that half needed choline, half didn't, and had a lot of noise in my data. Now that we can explain it, it makes sense. What seemed to be noisy data can be better described using a precision nutrition approach.
Are there other nutritional conundrums that suggest these sorts of variations are common?
There are some things for which we already know the underlying genetic reasons. For example, there's a great deal of information on genetic differences that make some people's cholesterol go up when they eat a high-fat diet while other people's doesn't. Researchers are discovering genetic variants that account for why some people need more vitamin D than others to get the same levels in their blood.
Every metabolic step is controlled by such variants. So, when we find people who seem to be responding differently in our studies, that's a hint that there is some underlying variation. Rather than throwing the data away or saying participants didn't comply with the study protocol, we can look at the data to discover some of the genetic reasons for these differences. Precision nutrition is really a change in how we do nutrition research, in that we're starting to identify why some people respond and some don't.
Besides genetic variants, are there other factors that precision nutrition needs to take into account?
Right now, much of our ability to be more precise comes from better tools to understand genetic variation. But genetics alone doesn't determine your response to nutrients. It interacts with other factors too.
The microbiome [the community of bacteria and other microbes that live in and on our body] clearly also affects how nutrients work. Most microbiome research until now has been to name the organisms in the gut, but it's now getting to the point where researchers can measure what microbial genes are switched on, what nutrients are made by gut microbes, and so on. As that research matures, we'll be able to get much better recommendations than we do now.
Our environment could be a very important factor as well. We're starting to be able to measure different environmental exposures by testing for thousands of chemicals in a drop of blood. Epigenetics, which is the science of chemical marks placed on DNA to turn genes on and off, will also likely contribute to important differences. It's been a hard field because these marks vary in different tissues, and we can't easily get a sample of liver or heart tissue for a nutrition test. We have to track these changes in the bloodstream, and estimate whether they're the same changes that occurred in the organs themselves.
We'll have to include each of these factors to improve our predictions of who will or won't respond to a certain nutrient. Eventually, precision nutrition will have all of these inputs at its early stages.
There are various precision nutrition tests now being sold by different companies. Do they have anything useful to offer?
Right now, most tests look at one gene at a time in a database and say, "You have this gene difference and it makes you more susceptible to something." But the metabolic pathways for most nutrients are not controlled by a single gene. There may be 10 or 20 steps that all add up to how you respond to sugars, for example, and any one of those steps can cause a problem. Knowing where you have variations all along the pathway can help us predict how likely you are to have a problem metabolizing sugar. It's more sophisticated, but it's also harder to do.
Are there ethical concerns with precision nutrition?
Once I know something about a person's genetics for nutrition, I may be able to predict that they're more likely to develop a disease or a health problem. That could change whether an insurance company wants to cover them. We have to try to make that risk clear to people, and also work on improving privacy so their information isn't available to anybody but them.
The other problem is that wealthier people can afford to do these genetic tests and others can't. But we can use precision nutrition to find alternate solutions. For instance, women who can't turn choline production genes on with the hormone estrogen are at higher risk of having babies with neural tube defects and poor brain development. If we need a test for only that one gene difference, a test like that could be reduced to a few dollars and made widely available. Or we might choose to just give everybody choline supplements, if that proves to be a more cost-effective solution.
In the long run, will these discoveries help prevent disease?
There is an advantage in seeking more precise advice for some problems right now. With obesity, for instance, we know that as people gain weight, they develop a group of problems called metabolic syndrome that's related to the accumulation of fat in the liver. We know that because of genetic differences, about 20 percent of the population is much more likely to develop fatty liver and is at higher risk for developing these related problems. If we can test for these gene differences, then we can identify those who will benefit the most from changes in diet and weight loss and treat them, either with supplements, drugs or lifestyle changes.
Salt sensitivity is another example. About 10 percent of people have higher blood pressure when they eat high-salt diets. Right now, because we don't know the metabolic differences that contribute, we say everybody should stay away from salt. But the truth is, only about 10 percent of people are benefiting from that recommendation, and 90 percent are getting bland food that they don't like. If we could do genetic testing and tell whether a person is salt-sensitive, then they know that effort is worth it for their health. I think that helps to make people comply with recommendations and change their lifestyles.
Unlike some drugs, which have an all-or-nothing effect, nutrition's effects tend to be modest. But it's clearly an important, easy intervention. And if we don't fix a diet, then we have to treat the problems that arise from a bad diet.
Nutrition is always going to be a tough field to get precise results. It isn't going to be perfect until we can get all the variables identified. Part of what precision nutrition is doing is helping to refine the tools we have to understand these complex systems.
This article originally appeared in Knowable Magazine, an independent journalistic endeavor from Annual Reviews. Sign up for the newsletter.
Go here to read the rest:
'Precision nutrition': Are hyper-individualized diets the future of eating? - The Week Magazine
- Dr Aisha Pandor: How this award winning Human Genetics scientist developed an app to help keep your house clean - IOL - October 16th, 2021
- Popular theory of Native American origins debunked by genetics and skeletal biology - EurekAlert - October 16th, 2021
- 10 Surprising Facts About Birth Control (That You Probably Never Knew) - YourTango - October 16th, 2021
- New stem cell identified by Sanford Burnham Prebys researchers offers hope to people with rare liver disease - Newswise - October 16th, 2021
- Bionano Genomics Announces ESHG Lineup Featuring 11 Customer Presentations of OGM Data Spanning Three Major Clinical Research Areas of Application... - August 31st, 2021
- Investing in the Power of Pathology and Genomics - Tufts Now - August 31st, 2021
- Humans are more than just a bag of genes - Commentary Box Sports - August 31st, 2021
- What Is the Most Important Scientific Development of the Last 50 Years? - Gizmodo Australia - August 31st, 2021
- 6 Greatest Breakthroughs in Agriculture that Changed the World - Krishi Jagran - August 31st, 2021
- Animal Expert Shares 5 Things That Will Help Your Dog Live a Longer, Healthier Life - ScienceAlert - August 31st, 2021
- Roman Catholics of Goa, Mangalore have early lineages of Brahmin community: Study - NewsMeter - August 31st, 2021
- The Poop About Your Gut Health and Personalized Nutrition - WIRED - August 31st, 2021
- Latest Research Strengthens Link Between Genetics and Suicidal Behaviors - University of Utah Health Care - July 21st, 2021
- Mixed-ancestry genetic research shows a bit of Native American DNA could reduce risk of Alzheimer's disease - The Conversation US - July 21st, 2021
- COVID-19 Roundup: The Unvaccinated Fuel Hospitalizations; Genetic Link to Severe Illness; and Children's Infection Rate - Baptist Health South Florida - July 21st, 2021
- Luck of the draw: How the random results of the genetic lottery can influence a host of your life's outcomes - Milwaukee Journal Sentinel - July 21st, 2021
- Kafer: The scary, promising and not too distant future of gene editing technology - The Denver Post - July 21st, 2021
- MUST READ OF THE WEEK: THE GENOME ODYSSEY BY DR EUAN ANGUS ASHLEY - Blackpool Gazette - July 21st, 2021
- Vence Bonham to be appointed acting NHGRI deputy director - National Human Genome Research Institute - June 6th, 2021
- UMaine researchers: Culture drives human evolution more than genetics - UMaine News - University of Maine - University of Maine - June 6th, 2021
- Myriad Genetics Recalibrates Breast Cancer PRS for All Ancestries in Anticipation of Broader Launch - Precision Oncology News - June 6th, 2021
- Amgen To Present At The Goldman Sachs 42nd Annual Global Healthcare Conference - Yahoo Finance - June 6th, 2021
- Unprecedented Data Sharing Drives New Rare Disease Diagnoses Just Tip of the Iceberg - SciTechDaily - June 6th, 2021
- New Approach to DNA Research Could Be Key to Solving Mysteries of Deadly Diseases - University of Virginia - June 6th, 2021
- Critics of Alberta's new rules for supervised consumption sites say they will curb access for vulnerable clients - The Globe and Mail - June 6th, 2021
- The 'Wondrous Map': Charting of the Human Genome, 20 Years Later - Medscape - December 16th, 2020
- Neuron23 Closes $113.5 Million Series A and B Financing led by Westlake Village BioPartners, Kleiner Perkins, and Redmile Group - PRNewswire - December 16th, 2020
- Leading UK Core Labs Expand Investment in PacBio Sequencing Systems to Power Life Science Research with HiFi Reads - GlobeNewswire - December 16th, 2020
- Unique genetic factors and ancestry, along with lifestyle, influence skin cancer risk - Kaiser Permanente Division of Research - December 16th, 2020
- NIH's All of Us Research Program returns first genetic results to participants - National Institutes of Health - December 16th, 2020
- ONLINE: Wednesday Nite at the Lab - Isthmus - December 16th, 2020
- Researchers identify the origin of a deadly brain cancer - McGill Newsroom - December 16th, 2020
- Meet the MBA Class of 2022: Christopher Connolly, University of Michigan (Ross) - Poets&Quants - December 16th, 2020
- Prevail Therapeutics Announces First Patient Dosed in Phase 1/2 PROCLAIM Clinical Trial Evaluating PR006 for the Treatment of Frontotemporal Dementia... - December 16th, 2020
- Differences, Demonization, and DNA | Opinion - Harvard Crimson - November 17th, 2020
- Weekend reads: Inside one of Hollywood's most famous hotels amid the Covid-19 epidemic - The Daily Briefing - November 7th, 2020
- First Line Sequencing Seen as a Win for Both Parents and Doctors of Infants in ICU - Clinical OMICs News - November 7th, 2020
- Largest Study To-Date Focused on Undiagnosed Genetic Disease Patients Reveals That Bionano's Optical Genome Mapping Technology Can Diagnose... - November 7th, 2020
- Experiencing happiness likely contributed to the dramatic growth and complexity of the human brain - Genetic Literacy Project - November 7th, 2020
- NIH researchers identify gene in mice that controls food cravings, desire to exercise - National Institutes of Health - November 7th, 2020
- Amgen To Present At The 29th Annual Credit Suisse Healthcare Conference - WFMZ Allentown - November 7th, 2020
- Prevail Therapeutics Announces Decisive Victory in Arbitration Brought by Alector against Prevail's CEO - GlobeNewswire - November 7th, 2020
- Focusing on the Future of Genetic Testing in Oncology - OncLive - October 10th, 2020
- ASHG 2020 Virtual Meeting to Showcase Innovative Research in Human Genetics - BioSpace - October 10th, 2020
- Evenings with Genetics discusses connection between cancer and genetics - Baylor College of Medicine News - October 10th, 2020
- Promoting global collaboration for brain health research - The BMJ - October 10th, 2020
- SKYMINT BRANDS -- Formerly Green Peak Innovations -- Joins Forces With DNA Genetics To Bring The World's Most Globally Awarded Flower Strains To... - October 10th, 2020
- U of T's Medicine by Design invests $1 million to advance new ideas in regenerative medicine - News@UofT - October 10th, 2020
- DCeased Proves Why Superboy Is the DC Universe's Gohan | CBR - CBR - Comic Book Resources - October 10th, 2020
- COVID-19 Shines Light on Disparities in Care for Patients With Cancer - OncLive - October 10th, 2020
- Genetic Study Uncovers Mutation Associated with Fibromuscular Dysplasia - University of Michigan Health System News - September 22nd, 2020
- Biopharm America: Of 'psychotic' behavior and term sheets in online dealmaking's brave new world - BioWorld Online - September 22nd, 2020
- 'It's all in the brain': The science behind stuttering - Genetic Literacy Project - September 22nd, 2020
- Jumpcode Genomics Exits Stealth Mode, Unveils Technology that Addresses the 'Needle in the Haystack' Problem of Molecular Biology - Bio-IT World - September 22nd, 2020
- Sex is real - aeon.co - September 22nd, 2020
- Coronavirus mutations: what we've learned so far - The Conversation UK - September 22nd, 2020
- Illumina to buy Jeff Bezos-backed cancer testing firm Grail in $8 billion deal - Metro US - September 22nd, 2020
- NeuBase Therapeutic's CEO, Dietrich A. Stephan, Ph.D., to Present at Tribe Public's Presentation and Q&A Webinar Event on August 26, 2020 - BioSpace - August 26th, 2020
- Canada Foundation for Innovation invests $9.3M in McGill highly-specialized research infrastructures - Science Business - August 26th, 2020
- Closing Gaps in Care: COVID-19 in Patients With Cancer Bring Health Inequities to the Surface - Targeted Oncology - August 26th, 2020
- Gains for humans, cows and the environment in breeding a socially acceptable cow - Dairy News Australia - August 26th, 2020
- Meet the Researcher: Xiaomei Cong, School of Nursing - UConn Today - August 26th, 2020
- Returning Weldon to head up full-time lab - Royal Gazette - August 26th, 2020
- Stanford alum investigates link between genomics and COVID-19 vulnerability - The Stanford Daily - August 16th, 2020
- The Secret to a Long, Healthy Life Is in the Genes of the Oldest Humans Alive - Singularity Hub - August 16th, 2020
- Humans have had mystery DNA for 300,000 yearsand now we might finally know what it is - SYFY WIRE - August 16th, 2020
- BUILDING THE NATION WITH QUALITY EDUCATION - The Star Online - August 16th, 2020
- Dairy culture on the Eurasian Steppe - Harvard Magazine - August 16th, 2020
- Race Is Real, But It's Not Genetic - Discover Magazine - June 30th, 2020
- Human Genetics Market 2020: Challenges, Growth, Types, Applications, Revenue, Insights, Growth Analysis, Competitive Landscape, Forecast- 2025 - Cole... - June 30th, 2020
- Seattle Genetics Announces Positive Topline Results from Phase 2 Clinical Trial of Tisotumab Vedotin in Recurrent or Metastatic Cervical Cancer -... - June 30th, 2020
- deCODE Genetics: Loss of Function Variant in FLT3 Strongly Increases the Risk of Autoimmune Thyroid Disease and Other Autoimmune Diseases - Yahoo... - June 30th, 2020
- Scientists and Societies Decry Trump Executive Order on Immigration Visas - Genetic Engineering & Biotechnology News - June 30th, 2020
- Unpicking the complexity of DNA mutations - Cambridge Network - June 30th, 2020
- And finally... Where there's muck, there's brass - Scottish Construction Now - June 30th, 2020
- Cause of Common Autoinflammatory Disease May Have Protected Ancestors From Plague - Technology Networks - June 30th, 2020
- After the MadnessPandemic Silver Linings in Bioscience - NEO.LIFE - June 5th, 2020
- First studies of human genetic variation released by gnomAD Consortium - Drug Target Review - June 5th, 2020
- Rocket, arugula, rucola: how genetics determines the health benefits and whether you like this leafy green - The Conversation UK - June 5th, 2020
- Intravacc Partners with Wageningen Bioveterinary Research and Utrecht University - Contract Pharma - June 5th, 2020